Paula K. Garrett - Feb 4, 2022 Form 4 Insider Report for FirstCash Holdings, Inc. (FCFS)

Role: Director
Signature: /s/ Paula K. Garrett
Stock symbol: FCFS
Transactions as of: Feb 4, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/8/2022, 04:24 PM
Next filing: Feb 3, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FCFS	Common Stock	Award	$0	+1.59K	+95.9%	$0.00	3.25K	Feb 4, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects a grant of restricted stock units ("RSUs") that shall vest on December 31, 2022 pursuant to the terms of the RSU award agreement or on a pro rata portion upon the termination of service other than for cause, with such pro rata portion determined based on the number of whole months that elapsed from the Grant Date to the termination of service; the vesting and payment of these RSUs will be accelerated if there is a change-in-control of the Company and the Units are not assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control. The number of RSUs was determined by dividing $110,000 by $69.11, the 45 day trailing average of the closing price of the Company's common stock on Nasdaq on the day of the grant.

Content

Reflects a grant of restricted stock units ("RSUs") that shall vest on December 31, 2022 pursuant to the terms of the RSU award agreement or on a pro rata portion upon the termination of service other than for cause, with such pro rata portion determined based on the number of whole months that elapsed from the Grant Date to the termination of service; the vesting and payment of these RSUs will be accelerated if there is a change-in-control of the Company and the Units are not assumed by the surviving entity or otherwise equitably converted or substituted in connection with the Change in Control. The number of RSUs was determined by dividing $110,000 by $69.11, the 45 day trailing average of the closing price of the Company's common stock on Nasdaq on the day of the grant.